BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36872348)

  • 1. E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function.
    Wei Y; Han S; Wen J; Liao J; Liang J; Yu J; Chen X; Xiang S; Huang Z; Zhang B
    J Biomed Sci; 2023 Mar; 30(1):17. PubMed ID: 36872348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.
    Qi T; Qu Q; Li G; Wang J; Zhu H; Yang Z; Sun Y; Lu Q; Qu J
    Am J Cancer Res; 2020; 10(10):3083-3105. PubMed ID: 33163259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression.
    Peng Y; Feng H; Wang C; Song Z; Zhang Y; Liu K; Cheng X; Zhao R
    Cell Death Dis; 2021 Apr; 12(5):427. PubMed ID: 33931578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells.
    Puli OR; Danysh BP; McBeath E; Sinha DK; Hoang NM; Powell RT; Danysh HE; Cabanillas ME; Cote GJ; Hofmann MC
    Neoplasia; 2018 Nov; 20(11):1121-1134. PubMed ID: 30265861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
    Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
    Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
    Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
    Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gene expression regulated by the ETV5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer.
    Llauradó M; Majem B; Castellví J; Cabrera S; Gil-Moreno A; Reventós J; Ruiz A
    Mol Cancer Res; 2012 Jul; 10(7):914-24. PubMed ID: 22589409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.
    Monge M; Colas E; Doll A; Gil-Moreno A; Castellvi J; Diaz B; Gonzalez M; Lopez-Lopez R; Xercavins J; Carreras R; Alameda F; Canals F; Gabrielli F; Reventos J; Abal M
    Carcinogenesis; 2009 Aug; 30(8):1288-97. PubMed ID: 19443906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX9 regulates expression of the male fertility gene Ets variant factor 5 (ETV5) during mammalian sex development.
    Alankarage D; Lavery R; Svingen T; Kelly S; Ludbrook L; Bagheri-Fam S; Koopman P; Harley V
    Int J Biochem Cell Biol; 2016 Oct; 79():41-51. PubMed ID: 27498191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
    Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
    J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS transcription factors: Multifaceted players from cancer progression to tumor immunity.
    Wang Y; Huang Z; Sun M; Huang W; Xia L
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188872. PubMed ID: 36841365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etv5, a transcription factor with versatile functions in male reproduction.
    Eo J; Song H; Lim HJ
    Clin Exp Reprod Med; 2012 Jun; 39(2):41-5. PubMed ID: 22816068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2.
    Eo J; Han K; M Murphy K; Song H; Lim HJ
    J Endocrinol; 2008 Aug; 198(2):281-90. PubMed ID: 18492810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs.
    Zhang F; Wang S; Zhu J
    J Biol Chem; 2020 Jul; 295(29):10062-10075. PubMed ID: 32518154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis.
    Lu BC; Cebrian C; Chi X; Kuure S; Kuo R; Bates CM; Arber S; Hassell J; MacNeil L; Hoshi M; Jain S; Asai N; Takahashi M; Schmidt-Ott KM; Barasch J; D'Agati V; Costantini F
    Nat Genet; 2009 Dec; 41(12):1295-302. PubMed ID: 19898483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.
    Gao H; Chen Z; Zhao L; Ji C; Xing F
    Biochim Biophys Acta Rev Cancer; 2024 Apr; 1879(3):189099. PubMed ID: 38582329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor Etv5 is essential for the maintenance of alveolar type II cells.
    Zhang Z; Newton K; Kummerfeld SK; Webster J; Kirkpatrick DS; Phu L; Eastham-Anderson J; Liu J; Lee WP; Wu J; Li H; Junttila MR; Dixit VM
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3903-3908. PubMed ID: 28351980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.